All In MedTech

FDA Clearance Tracker · P010039

SIEMENS SONOCUR BASIC SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jul 19, 2002 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jul 19, 2002

Approval withdrawn

Time to decision

357 days

Received Jul 27, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P010039
Device name
SIEMENS SONOCUR BASIC SYSTEM
Applicant location
Mavern, PA
Received
Jul 27, 2001
Decided
Jul 19, 2002
Decision
Approval withdrawn
Supplements
2 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NBN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SIEMENS SONOCUR BASIC. THE SIEMENS SONOCUR BASIC IS A NON-SURGICAL ALTERNATIVE FOR THE TREATMENT OF CHRONIC LATERAL EPICONDYLITIS (COMMONLY REFERRED TO AS TENNIS ELBOW) FOR PATIENTS WITH SYMPTOMS OF CHRONIC LATERAL EPICONDYLITIS FOR 6 MONTHS OR MORE AND A HISTORY OF UNSUCCESSFUL CONSERVATIVE TREATMENTS.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NBN. The earliest in FDA's data is P990086, decided Oct 12, 2000.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Siemens Medical Solutions USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.